Cas 914386-62-2,N-[3-(4-fluorophenyl)-3-(4-methanesulfonylphenyl)propyl]-6-hydroxy-nicotinamide

914386-62-2

Post Buying Request

Basic information

Product Name: N-[3-(4-fluorophenyl)-3-(4-methanesulfonylphenyl)propyl]-6-hydroxy-nicotinamide
Synonyms: N-[3-(4-fluorophenyl)-3-(4-methanesulfonylphenyl)propyl]-6-hydroxy-nicotinamide
CAS NO:914386-62-2
Molecular Formula:
Molecular Weight: 428.484
EINECS: N/A
Product Categories: N/A
Mol File: 914386-62-2.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N-[3-(4-fluorophenyl)-3-(4-methanesulfonylphenyl)propyl]-6-hydroxy-nicotinamide(CAS DataBase Reference)
NIST Chemistry Reference: N-[3-(4-fluorophenyl)-3-(4-methanesulfonylphenyl)propyl]-6-hydroxy-nicotinamide(914386-62-2)
EPA Substance Registry System: N-[3-(4-fluorophenyl)-3-(4-methanesulfonylphenyl)propyl]-6-hydroxy-nicotinamide(914386-62-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 914386-62-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

914386-62-2 Suppliers

Recommended suppliersmore

914386-62-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 914386-62-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,4,3,8 and 6 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 914386-62:
(8*9)+(7*1)+(6*4)+(5*3)+(4*8)+(3*6)+(2*6)+(1*2)=182
182 % 10 = 2
So 914386-62-2 is a valid CAS Registry Number.

914386-62-2Upstream product

914386-62-2Downstream Products

914386-62-2Relevant articles and documents

Structure-based optimization of arylamides as inhibitors of soluble epoxide hydrolase

Eldrup, Anne B.,Soleymanzadeh, Fariba,Taylor, Steven J.,Muegge, Ingo,Farrow, Neil A.,Joseph, David,McKellop, Keith,Man, Chuk C.,Kukulka, Alison,De Lombaert, Stéphane

experimental part, p. 5880 - 5895 (2010/03/24)

Inhibition of soluble epoxide hydrolase (sEH) is hypothesized to lead to an increase in circulating levels of epoxyeicosatrienoic acids, resulting in the potentiation of their in vivo pharmacological properties. As part of an effort to identify inhibitors

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 914386-62-2